StocksU › UFPI

UFP Industries, Inc. (UFPI) — Earnings Call X-Ray

Our AI read all 39 of UFPI's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2025 · sign up to see
Previous Call Grade
C
Q4 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
39
2016–2025
Avg Candor
7.2/9
evasion 2.4/9
Guidance LoweredHigh CandorCritic AmmunitionEarly Product, Fast GrowthUnderused Fixed CostsPricing Under PressureMargins ContractingDemand Slowing

Call-by-call analysis

🔒 Q1 2025 earnings call 2025-04-29 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2025 call grade is ready
The full 37-point AI read of UFPI's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q4 2024 earnings call 2025-02-18 move ±7.7%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: contractingPricing: under pressureHeadcount: cuttingCapex: increasing 4 analysts · 11 questions
⚑ Critic ammunition✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthHidden segmentCFO dominates
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 6/9
Promotion 4/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q3 2024 earnings call 2024-10-29 move ±8%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: contractingPricing: under pressureHeadcount: cuttingCapex: increasing 4 analysts · 10 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubts✓ Early product, fast growthDirection beats results
Candor 8/9
Specificity 7/9
Evasion 2/9
Confidence 6/9
Uncertainty 6/9
Promotion 3/9
Stress 4/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q2 2024 earnings call 2024-07-30 move ±11.2%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: contractingPricing: under pressureHeadcount: flatCapex: increasing 5 analysts · 11 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 5/9
Promotion 4/9
Stress 3/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q1 2024 earnings call 2024-04-30 move ±7.3%

Management lowered guidance against slowing demand. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: stablePricing: under pressureHeadcount: flatCapex: increasing 4 analysts · 10 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthDirection beats results
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 6/9
Promotion 4/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B+ Q4 2023 earnings call 2024-02-20 move ±8.7%

Management raised guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: mixedMargins: contractingPricing: under pressureHeadcount: flatCapex: increasing 5 analysts · 15 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 6/9
Promotion 4/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C Q3 2023 earnings call 2023-10-31 move ±8.2%

Management lowered guidance against slowing demand. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: stableBacklog: shrinkingPricing: under pressureHeadcount: flatCapex: flat 3 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 7/9
Evasion 2/9
Confidence 7/9
Uncertainty 6/9
Promotion 3/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q2 2023 earnings call 2023-08-02 move ±7.6%

Management held guidance steady against mixed demand signals. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: mixedMargins: stablePricing: under pressureHeadcount: flatCapex: decreasing 3 analysts · 9 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 5/9
Promotion 4/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q1 2023 2023-05-02 C+ maintainedmixedcontracting 7/9 2/9
Q4 2022 2023-02-21 C+ loweredslowingcontracting 8/9 2/9
Q3 2022 2022-10-20 C+ maintainedmixedexpanding 7/9 3/9
Q2 2022 2022-07-21 C+ maintainedmixedexpanding 7/9 2/9
Q1 2022 2022-04-21 C+ maintainedmixedexpanding 7/9 3/9
Q4 2021 2022-02-16 B+ raisedstableexpanding 7/9 2/9
Q3 2021 2021-10-20 C+ maintainedmixedcontracting 7/9 3/9
Q2 2021 2021-07-21 B maintainedmixedexpanding 8/9 2/9
Q1 2021 2021-04-21 B+ maintainedacceleratingexpanding 7/9 1/9
Q4 2020 2021-02-24 B+ raisedacceleratingexpanding 8/9 2/9
Q3 2020 2020-10-22 B maintainedacceleratingexpanding 7/9 2/9
Q3 2020 2020-10-22 B maintainedacceleratingexpanding 8/9 2/9
Q2 2020 2020-07-23 B+ raisedacceleratingexpanding 7/9 2/9
Q1 2020 2020-05-10 D withdrawnmixedexpanding 7/9 5/9
Q4 2019 2020-02-21 B+ maintainedstableexpanding 7/9 2/9
Q3 2019 2019-10-24 B+ maintainedstableexpanding 7/9 3/9
Q2 2019 2019-07-26 B maintainedstableexpanding 7/9 3/9
Q1 2019 2019-04-26 B maintainedstableexpanding 7/9 2/9
Q4 2018 2019-02-22 B maintainedstableexpanding 7/9 2/9
Q3 2018 2018-10-17 C+ loweredmixedcontracting 8/9 2/9
Q2 2018 2018-07-19 C+ maintainedstablecontracting 7/9 3/9
Q1 2018 2018-04-19 C maintainedstablecontracting 6/9 4/9
Q4 2017 2018-02-23 B+ maintainedstablecontracting 8/9 2/9
Q3 2017 2017-10-18 B+ maintainedacceleratingcontracting 7/9 2/9
Q2 2017 2017-07-19 C+ maintainedacceleratingcontracting 8/9 2/9
Q1 2017 2017-04-19 B maintainedacceleratingcontracting 7/9 2/9
Q4 2016 2017-02-23 C+ maintainedacceleratingcontracting 7/9 3/9
Q3 2016 2016-10-19 B+ maintainedmixedstable 6/9 3/9
Q2 2016 2016-07-21 C maintainedmixedexpanding 6/9 4/9
Q1 2016 2016-04-21 B+ noneacceleratingexpanding 7/9 2/9
Q4 2015 2016-02-18 B+ maintainedmixedexpanding 7/9 2/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of UFPI's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

C Q1 2018 earnings call 2018-04-19

2 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

UFI   All “U” companies    UFPT

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.